Without knowing the source tissues of secretagogin, they found that the T2D population (n = 260) had elevated plasma levels of secretagogin compared with non-T2D individuals (n = 745) (p-value = 0.02) in their cohort [39]. The gene discussed is SCGN; the disease is type 2 diabetes mellitus.